학술논문
A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase
Document Type
Article
Author
Source
In Blood Cells, Molecules and Diseases December 2014 53(4):253-260
Subject
Language
ISSN
1079-9796